In the present study, the expression of hMOF was frequently downregulated in the clinical ovarian cancer tissues (Figs. 1 and 2) and, more notably, HCP5 was presented in gene expression profiles as a hMOF-downregulated gene. The gene discussed is HCP5; the disease is ovarian carcinoma.